Cyclosporine Patents

Given below is the list of patents protecting Cyclosporine, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Cyclosporine's patents.

Latest Legal Activities on Cyclosporine's Patents

Given below is the list recent legal activities going on the following patents of Cyclosporine.

Activity	Date	Patent Number
Today's Critical Events
Payment of Maintenance Fee, 12th Year, Large Entity	23 Apr, 2024	US8298568
Payment of Maintenance Fee, 4th Year, Large Entity	19 Apr, 2024	US10813976
Payment of Maintenance Fee, 12th Year, Large Entity	09 Apr, 2024	US8292129
Payment of Maintenance Fee, 8th Year, Large Entity	21 Jun, 2023	US9220694
Electronic Review Critical	24 May, 2023	US11413323
Post Issue Communication - Certificate of Correction	05 May, 2023	US11413323
Recordation of Patent Grant Mailed Critical	28 Mar, 2023	US11612658
Patent Issue Date Used in PTA Calculation Critical	28 Mar, 2023	US11612658
Email Notification Critical	09 Mar, 2023	US11612658
Payment of Maintenance Fee, 8th Year, Large Entity	09 Mar, 2023	US9132071

Cyclosporine's Family Patents

Full family tree